Tune in to our upcoming broadcast to learn more about advances in the treatment of tenosynovial giant cell tumor. Register today!

Should All Patients With Breast Cancer Get Chemotherapy?

Saturday, June 29, 2019

Healthcare providers were previously overtreating patients with breast cancer, giving many of them chemotherapy, explained Jesus Anampa, MD, MS, professor of Medicine at the Albert Einstein College of Medicine. 

Researchers on the TAILORx study randomized patients with intermediate-risk disease to receive chemotherapy plus endocrine therapy (standard of care) or endocrine therapy alone. Findings showed that endocrine therapy alone was noninferior for most patients, though women who were younger than 50 years old saw a benefit with the addition of chemotherapy. 

Anampa emphasized that these findings are particularly important as we move toward more biomarker-driven care in breast cancer.

Talk about this article with nurses and others in the oncology community in the General Discussions Oncology Nursing News discussion group.
External Resources

MJH Associates
American Journal of Managed Care
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
OncNurse Resources

Continuing Education
Web Exclusives

About Us
Advisory Board
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.